These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37610289)

  • 1. The synthesis and characterization of a series of cocrystals of an isoniazid derivative with butan-2-one and propan-2-one.
    Scheepers MC; Lemmerer A
    Acta Crystallogr C Struct Chem; 2023 Sep; 79(Pt 9):365-373. PubMed ID: 37610289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent-assisted supramolecular synthesis: the effect of hydrogen bonding in cocrystals of 4-tert-butylbenzoic acid with isoniazid and its derivatized forms.
    Madeley LG; Levendis DC; Lemmerer A
    Acta Crystallogr C Struct Chem; 2019 Feb; 75(Pt 2):200-207. PubMed ID: 30720459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinnamic acid hydrogen bonds to isoniazid and N'-(propan-2-ylidene)isonicotinohydrazide, an in situ reaction product of isoniazid and acetone.
    Sarcevica I; Orola L; Veidis MV; Belyakov S
    Acta Crystallogr C Struct Chem; 2014 Apr; 70(Pt 4):392-5. PubMed ID: 24705055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rietveld refinement of the cocrystal 2,4-dihydroxybenzoic acid-N'-(propan-2-ylidene)nicotinohydrazide (1/1).
    Lapidus SH; Lemmerer A; Bernstein J; Stephens PW
    Acta Crystallogr C; 2012 Sep; 68(Pt 9):o335-7. PubMed ID: 22935498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binary polymorphic cocrystals: an update on the available literature in the Cambridge Structural Database, including a new polymorph of the pharmaceutical 1:1 cocrystal theophylline-3,4-dihydroxybenzoic acid.
    Mnguni MJ; Michael JP; Lemmerer A
    Acta Crystallogr C Struct Chem; 2018 Jun; 74(Pt 6):715-720. PubMed ID: 29870007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structures of cocrystals of 2,7-dihydroxynaphthalene with isoniazid and piracetam.
    González-González JS; Valiente Flores ME; Flores-Alamo M; Macías-López E; Martínez-Martínez FJ; García-Ortega H
    Acta Crystallogr C Struct Chem; 2022 May; 78(Pt 5):280-286. PubMed ID: 35510433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supramolecular interactions in cocrystals of benzoic acid derivatives with selective COX-2 inhibitor etoricoxib.
    Ma YH; Yang K; Qian YL; Hong WP; Zhang KY; Tao ZW; Meng H; Ma WJ
    Acta Crystallogr C Struct Chem; 2024 Aug; 80(Pt 8):366-374. PubMed ID: 38967632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-State Versatility of the Molecular Salts/Cocrystals of 2-Chloro-4-nitrobenzoic Acid: A Case Study on Halogen Bonds.
    Oruganti M; Nechipadappu SK; Khade PA; Trivedi DR
    ACS Omega; 2017 Oct; 2(10):7146-7162. PubMed ID: 31457294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-drug cocrystals of antituberculous 4-aminosalicylic acid: Screening, crystal structures, thermochemical and solubility studies.
    Drozd KV; Manin AN; Churakov AV; Perlovich GL
    Eur J Pharm Sci; 2017 Mar; 99():228-239. PubMed ID: 28011126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocrystals of acyclovir with promising physicochemical properties.
    Sarkar A; Rohani S
    J Pharm Sci; 2015 Jan; 104(1):98-105. PubMed ID: 25407552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
    Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
    Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of varying quantities of polymer on preparation and stability evaluation of carbamazepine cocrystals with dicarboxylic acid coformers.
    Wasim M; Mannan A; Ullah K; Yameen MA; Latif M; Ahmad T; Ullah M; Amirzada MI; Khan HU; Maheen S; Khan SA; Jamil QA; Bin Asad MHH; Hussain I
    Pak J Pharm Sci; 2020 Jul; 33(4(Supplementary)):1755-1761. PubMed ID: 33612458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
    Basavoju S; Boström D; Velaga SP
    Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New cocrystals of heterocyclic drugs: structural, antileishmanial, larvicidal and urease inhibition studies.
    Murtaza G; Khan M; Farooq S; Choudhary MI; Yousuf S
    Acta Crystallogr C Struct Chem; 2023 Jun; 79(Pt 6):237-248. PubMed ID: 37140892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of two series of 1:1 cocrystals involving 4-amino-5-chloro-2,6-dimethylpyrimidine and carboxylic acids.
    Rajam A; Muthiah PT; Butcher RJ; Jasinski JP; Wikaira J
    Acta Crystallogr C Struct Chem; 2018 Sep; 74(Pt 9):1007-1019. PubMed ID: 30191892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Chloro-4-nitrobenzoic acid as a coformer with pharmaceutical cocrystals and molecular salts.
    Lemmerer A
    Acta Crystallogr C Struct Chem; 2020 Aug; 76(Pt 8):746-752. PubMed ID: 32756037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid State Characterization and Dissolution Enhancement of Nevirapine Cocrystals.
    Panzade P; Shendarkar G; Kulkarni D; Shelke S
    Adv Pharm Bull; 2021 Sep; 11(4):772-776. PubMed ID: 34888225
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparation, structural analysis, and properties of tenoxicam cocrystals.
    Patel JR; Carlton RA; Needham TE; Chichester CO; Vogt FG
    Int J Pharm; 2012 Oct; 436(1-2):685-706. PubMed ID: 22841852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-state versatility in tranexamic acid drug: structural and thermal behavior of new salts and cocrystals.
    Nechipadappu SK; Balasubramanian S
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2023 Feb; 79(Pt 1):78-97. PubMed ID: 36748901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piroxicam cocrystals with phenolic coformers: preparation, characterization, and dissolution properties.
    Emami S; Adibkia K; Barzegar-Jalali M; Siahi-Shadbad M
    Pharm Dev Technol; 2019 Feb; 24(2):199-210. PubMed ID: 29557714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.